Beekeepers in Australia are facing a dire threat from the varroa destructor mite, a tiny yet devastating pest that has been wreaking havoc on their livelihoods. The mite, which has been present in the country since 2022, has caused an estimated 90% loss of wild honey bee populations in some regions. This has led to a growing concern among beekeepers, with many expressing their fear of the unknown and the potential for their industry to collapse. The situation is particularly dire in South Australia, where the mite was first detected in September, and where beekeepers are desperate for new solutions to combat the pest.
One potential solution that has emerged is a biopesticide called Norroa, which has been developed by a research team led by Professor Phil Lester of Victoria University of Wellington. This innovative approach uses double-stranded RNA to silence reproductive genes in the mites, making them infertile and unable to lay eggs. The product has shown promising results in the United States, where it is commercially available, and beekeepers like Ian Cass are eagerly awaiting its introduction in Australia.
Cass, a South Australian beekeeper, has been closely monitoring the progress of Norroa and believes it could be a game-changer for the industry. He highlights the urgency of the situation, stating that the beekeeping community is terrified and that the current treatments are becoming less effective due to resistance. The industry-wide survey conducted by the Australian Honey Bee Industry Council in 2026 revealed that 32.2% of respondents were considering leaving the industry, with the varroa mite as the primary reason. This statistic underscores the dire situation and the need for immediate action.
However, the Australian government's response has been cautious. The Department of Primary Industries in South Australia advises beekeepers to continue using existing treatments, such as synthetic pyrethroid- and formamidines-based acaricides, which remain effective against susceptible populations. While these treatments have been successful in the past, the growing resistance among the mites is a cause for concern. The department encourages beekeepers to report suspected cases of treatment resistance, indicating a recognition of the issue but also a reluctance to embrace new solutions.
The development of Norroa represents a significant breakthrough in the fight against the varroa mite. Its potential to stop the growth of mite populations and its safety for bees offer a promising alternative to traditional acaricides. However, the timeline for its availability in Australia is a concern, with Professor Lester estimating it could take up to two years. This delay is a critical factor in the ongoing struggle against the mite, and beekeepers are pleading for investment and faster implementation of this innovative solution.
In conclusion, the battle against the varroa destructor mite is far from over. The situation in Australia is a stark reminder of the vulnerability of the beekeeping industry and the need for innovative solutions. While existing treatments have their merits, the growing resistance among the mites demands a fresh approach. The development of Norroa offers a glimmer of hope, but the timeline for its availability and the government's cautious response highlight the challenges that lie ahead. As beekeepers continue to fight for their livelihoods, the industry eagerly awaits the introduction of this biopesticide, hoping it will provide the much-needed relief they desperately seek.
